tradmap

UFPT Ufp Technologies Inc

$239.29 +5.34%

Healthcare · Surgical & Medical Instruments & Apparatus

Ufp Technologies Inc (UFPT) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $1.9 billion. Shares last traded at $239.29, 12.4% below their 52-week high. Over the past year the stock is up 1.4%. UFPT trades at a price-to-earnings ratio of 27.10, below the Surgical & Medical Instruments & Apparatus median of 28.73. Net profit margin is 11.3%, above the peer median of -7.6%. Revenue grew 19.5% year over year.

Market Cap
$1.9B
Shares Out
7.7M
EPS (TTM)
$8.75
P/E Ratio
27.35
P/S Ratio
3.07
P/B Ratio
4.22
Dividend / Share
Dividend Yield
52-Week High
$273.29
52-Week Low
$173.77
Volume
15,895
Avg Vol (3m)
10,485.587

Performance

1W
+0.35%
1M
+9.98%
3M
+21.34%
6M
+9.80%
YTD
+7.02%
1Y
+1.43%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
63.39
SMA (50)
$215.03
SMA (200)
$217.79
Price vs SMA50
+11.28%
Price vs SMA200
+9.87%
ATR (14)
$10.57

Financials

Revenue
$603M
Net Income
$68M
Gross Margin
28.3%
Operating Margin
15.3%
Net Margin
11.3%
Return on Equity
15.6%
Return on Assets
10.1%
Current Ratio
2.91
Debt / Equity
0.31
Revenue Growth (YoY)
+19.5%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $2.24 2026-05-08
FY 2025 $8.75 2026-02-27
FY 2025 $2.11 2026-02-27
FY 2025 $2.21 2026-02-27
Q1 2026 $2.21 2026-05-08
FY 2025 $7.58 2026-02-27

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

UFPT vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/E vs peers
27.10 / 28.73 med
-6% discount
P/S vs peers
3.07 / 2.52 med
+22% premium
Net margin vs peers
11.3% / -7.6% med
above median
1–14 of 14
SYKStryker Corporation$118.1B36.384.7012.9%+2.28%
MMM3M$83.9B25.823.3613.0%+1.10%
BSXBoston Scientific$67.3B23.273.3514.4%+0.64%
BDXBecton Dickinson$39.7B23.641.827.7%+1.62%
MDLNMedline Inc.$29.4B-1.47%
DXCMDexCom$28.0B33.436.0017.9%+1.69%
RMDResMed$27.4B19.535.3227.2%+1.24%
WSTWest Pharmaceutical Services$23.2B46.927.5416.1%+1.35%
SOLVSolventum$13.1B+1.21%
PENPenumbra Inc$12.5B70.188.8812.7%+0.28%
GMEDGlobus Medical Inc$10.8B19.993.6618.3%+5.00%
BAXBaxter International$10.3B-10.740.91-8.5%+2.58%
PODDInsulet Corporation$10.1B40.843.739.1%+1.51%
GKOSGlaukos Corp$7.7B-40.9215.13-37.0%+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.